We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tiziana Life Sciences Plc | LSE:TILS | London | Ordinary Share | GB00BKWNZY55 | ORD 3P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 58.50 | 45.00 | 60.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
28/11/2017 08:49 | £4 from broker again. | stenick | |
24/11/2017 13:32 | Hopefully some income soon. Kunwar Shailubhai, CEO & CSO of Tiziana Life Sciences, commented: "Data from these two clinical studies demonstrating efficacy and long-term safety is a major milestone in clinical development of milciclib. We will work with regulatory agencies in US and Europe to develop plans to bring these first-in-class therapies to patients in need as soon as possible.” | stenick | |
23/11/2017 15:27 | Agreed Jpuff. Tils has all the makings of a successful company. Can’t wait for news on liver cancer trial and foralumab trial. | stenick | |
23/11/2017 08:03 | Well under the radar TILS and a good time to accumulate imho. | jpuff | |
23/11/2017 07:59 | Brilliant, did not realise some people have been taking it for over 5yrs. | stenick | |
23/11/2017 07:16 | Excellent news above. | jpuff | |
09/11/2017 14:27 | ???????????????????? | rovi70 | |
31/10/2017 16:03 | 🙉🙊 | stenick | |
31/10/2017 15:24 | gosh!!!!!! | rovi70 | |
04/10/2017 08:16 | Somethings going on I bet. What it is, I don’t know . But something is going on. IMO. | stenick | |
03/10/2017 21:53 | TILS. Beaufort Securities Speculative Buy 150.50 149.00 400.00 400.00 Reiterates | rovi70 | |
13/9/2017 12:13 | Price not changing on buys and drops quick on sales. I reckon it is a placing to institutional investor at say £1.50p . Hope it is. iMO | stenick | |
12/9/2017 14:41 | Possibly raising some more cash with an institutional investment, but I don't know really, nothing has changed, Milciclib is still working and foralumab is all go now, so we wait. | stenick | |
12/9/2017 12:30 | Oh dear prophetic words from me above been sliding since! Any views on what's going on here guys? | jpuff | |
28/7/2017 16:19 | Strong buying interest, deservedly so and still well under the radar. As a long term firm holder I've great confidence here. GLA, best regards Jpuff | jpuff | |
28/7/2017 08:50 | This could be a blockbuster in the making. | jpuff | |
12/7/2017 17:49 | Tidying up for the buyout maybe 🤔 | stenick | |
06/7/2017 13:26 | Thanks rovi 😃 | stenick | |
06/7/2017 11:18 | 356 v up was me Sten. | rovi70 | |
06/7/2017 10:36 | Thanks Jpuff, it works alright. | stenick | |
06/7/2017 09:36 | I just voted 358 up as a test do take a look Stenick regards Jpuff | jpuff |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions